Epilepsy Surgery in Young Children With Tuberous Sclerosis Complex: A Novel Hybrid Multimodal Surgical Approach. Issue 2 (10th November 2022)
- Record Type:
- Journal Article
- Title:
- Epilepsy Surgery in Young Children With Tuberous Sclerosis Complex: A Novel Hybrid Multimodal Surgical Approach. Issue 2 (10th November 2022)
- Main Title:
- Epilepsy Surgery in Young Children With Tuberous Sclerosis Complex: A Novel Hybrid Multimodal Surgical Approach
- Authors:
- Ravindra, Vijay M.
Karas, Patrick J.
Lazaro, Tyler T.
Coorg, Rohini
Awad, Al-Wala
Patino, Ilana
McClernon, Emily E.
Clarke, Dave
Cairampoma Whitehead, Laura
Anderson, Anne
Diaz-Medina, Gloria
Houck, Kimberly
Katyayan, Akshat
Masters, Laura
Nath, Audrey
Quach, Michael
Riviello, James
Seto, Elaine S.
Sully, Krystal
Agurs, Latanya
Sen, Sonali
Handoko, Maureen
LoPresti, Melissa
Ali, Irfan
Curry, Daniel J.
Weiner, Howard L. - Abstract:
- Abstract : BACKGROUND: Surgery has become integral in treating children with tuberous sclerosis complex (TSC)–related drug-resistant epilepsy (DRE). OBJECTIVE: To describe outcomes of a multimodal diagnostic and therapeutic approach comprising invasive intracranial monitoring and surgical treatment and compare the complementary techniques of open resection and magnetic resonance–guided laser interstitial thermal therapy. METHODS: Clinical and radiographic data were prospectively collected for pediatric patients undergoing surgical evaluation for TSC-related DRE at our tertiary academic hospital. Seizure freedom, developmental improvement, and Engel class were compared. RESULTS: Thirty-eight patients (20 females) underwent treatment in January 2016 to April 2019. Thirty-five underwent phase II invasive monitoring with intracranial electrodes: 24 stereoencephalography, 9 craniotomy for grid/electrode placement, and 2 grids + stereoencephalography. With the multimodal approach, 33/38 patients (87%) achieved >50% seizure freedom of the targeted seizure type after initial treatment; 6/9 requiring secondary treatment and 2/2 requiring a third treatment achieved >50% freedom. The median Engel class was II at last follow-up (1.65 years), and 55% of patients were Engel class I/II. The mean age was lower for children undergoing open resection (2.4 vs 4.9 years, P = .04). Rates of >50% reduction in seizures (86% open resection vs 88% laser interstitial thermal therapy) andAbstract : BACKGROUND: Surgery has become integral in treating children with tuberous sclerosis complex (TSC)–related drug-resistant epilepsy (DRE). OBJECTIVE: To describe outcomes of a multimodal diagnostic and therapeutic approach comprising invasive intracranial monitoring and surgical treatment and compare the complementary techniques of open resection and magnetic resonance–guided laser interstitial thermal therapy. METHODS: Clinical and radiographic data were prospectively collected for pediatric patients undergoing surgical evaluation for TSC-related DRE at our tertiary academic hospital. Seizure freedom, developmental improvement, and Engel class were compared. RESULTS: Thirty-eight patients (20 females) underwent treatment in January 2016 to April 2019. Thirty-five underwent phase II invasive monitoring with intracranial electrodes: 24 stereoencephalography, 9 craniotomy for grid/electrode placement, and 2 grids + stereoencephalography. With the multimodal approach, 33/38 patients (87%) achieved >50% seizure freedom of the targeted seizure type after initial treatment; 6/9 requiring secondary treatment and 2/2 requiring a third treatment achieved >50% freedom. The median Engel class was II at last follow-up (1.65 years), and 55% of patients were Engel class I/II. The mean age was lower for children undergoing open resection (2.4 vs 4.9 years, P = .04). Rates of >50% reduction in seizures (86% open resection vs 88% laser interstitial thermal therapy) and developmental improvement (86% open resection vs 83% magnetic resonance–guided laser interstitial thermal therapy) were similar. CONCLUSION: This hybrid approach of using both open surgical and minimally invasive techniques is safe and effective in treating DRE secondary to TSC. Clinical trials focused on treatment method with longer follow-up are needed to determine the optimal candidates for each approach and compare the treatment modalities more effectively. Abstract : … (more)
- Is Part Of:
- Neurosurgery. Volume 92:Issue 2(2023)
- Journal:
- Neurosurgery
- Issue:
- Volume 92:Issue 2(2023)
- Issue Display:
- Volume 92, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 92
- Issue:
- 2
- Issue Sort Value:
- 2023-0092-0002-0000
- Page Start:
- 398
- Page End:
- 406
- Publication Date:
- 2022-11-10
- Subjects:
- Craniotomy -- Electrocorticography -- Laser ablation -- Medically refractory epilepsy -- Pediatric epilepsy -- Stereoelectroencephalography -- Tuberous sclerosis
Nervous system -- Surgery -- Periodicals
617.48005 - Journal URLs:
- https://academic.oup.com/neurosurgery ↗
http://www.neurosurgery-online.com ↗
https://journals.lww.com/neurosurgery/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1227/neu.0000000000002214 ↗
- Languages:
- English
- ISSNs:
- 0148-396X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.582000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25128.xml